SmartNuclide is Drug Discovery in China that focus on therapeutics formulations business. Founded in 2015. They cover business area such as developer, researcher, biopharmaceutical, molecular nuclear oncology, innovative biological drug product, both diagnostic, therapeutic formulation, molecular oncology, reliable and effective product, well cancer treatment.
2015
( 9 years old in 2024 )
Therapeutics Formulations
-
218 Xinghu Street, BioBAY A4-202
Suzhou Industrial Park
Suzhou, Jiangsu
China
Private
developerresearcherbiopharmaceuticalmolecular nuclear oncologyinnovative biological drug productboth diagnostictherapeutic formulationmolecular oncologyreliable and effective productwell cancer treatment
* We use standard office opening hours in near SmartNuclide's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SmartNuclide is Drug Discovery business from China that founded in 2015 (9 years old in 2024), SmartNuclide business is focusing on Therapeutics Formulations.
SmartNuclide headquarter office and corporate office address is located in 218 Xinghu Street, BioBAY A4-202 Suzhou Industrial Park Suzhou, Jiangsu China.
SmartNuclide was founded in China.
In 2024, SmartNuclide is currently focus on therapeutics formulations sector.
Above is snippet of Google Trends for "therapeutics formulations" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SmartNuclide, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.